NEWS (January 30, 2020)

Baker McKenzie advised shareholders of Biopharma

The Kyiv office of Baker McKenzie advised the shareholders of Biopharma, a leading Ukrainian manufacturer of pharmaceuticals and healthcare products, on the carve-out of its non-plasma business and its further sale to Stada AG, a global manufacturer of pharmaceuticals and consumer healthcare products.
The Baker McKenzie team was co-led by Kyiv office partners Viacheslav Yakymchuk, head of the Corporate M&A practice group, and Olha Demianiuk, head of the Healthcare & Life Sciences industry group, with key input from associates Andrii FinoginOlha Sviatenka and Khrystyna Penyk , and London-based senior corporate associate Robert Gray. The team also included antitrust and competition partner Oksana Simonova and senior associate Olha Mikheieva


The Ukrainian Journal of Business Law

Subscribe to The Ukrainian Journal of Business Law right now and enjoy the most relevant issues on doing business in Ukraine on your device or in print.

All this for just USD 9.99 a month.


Subscribe now